{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:17:18Z","timestamp":1760347038735,"version":"3.37.3"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"Hospital fund project from Guangzhou Women and Children\u2019s Medical Center","doi-asserted-by":"publisher","award":["Pre-NSFC-2019\u2013013"],"award-info":[{"award-number":["Pre-NSFC-2019\u2013013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>GM1 gangliosidosis (GM1) is an autosomal recessive disorder characterized\nby the deficiency of beta-galactosidase (\u03b2-gal), a ubiquitous lysosomal enzyme that catalyzes the hydrolysis\nof GM1 ganglioside.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The study aims to explore the application of the AAV9-coGLB1 for effective treatment in a\nGM1 gangliosidosis mutant mouse model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We designed a novel adeno-associated virus 9 (AAV9) vector expressing \u03b2-gal (AAV9-\ncoGLB1) to treat GM1 gangliosidosis. The vector, injected via the caudal vein at 4 weeks of age,\ndrove the widespread and sustained expression of \u03b2-gal for up to 32 weeks in the Glb1G455R\/G455R mutant\nmice (GM1 mice).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The increased levels of \u03b2-gal reduced the pathological damage occurring in GM1 mice. Histological\nanalyses showed that myelin deficits and neuron-specific pathology were reduced in the cerebral\ncortex region of AAV9-coGLB1-treated mice. Immunohistochemical staining showed that the\naccumulation of GM1 ganglioside was also reduced after gene therapy. The reduction of the storage in\nthese regions was accompanied by a decrease in activated microglia. In addition, AAV9 treatment reversed\nthe blockade of autophagic flux in GM1 mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These results show that AAV9-coGLB1 reduces the pathological signs of GM1 gangliosidosis\nin a mouse model.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566523222666220304092732","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T06:28:07Z","timestamp":1646634487000},"page":"352-365","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["AAV9-coGLB1 Improves Lysosomal Storage and Rescues Central Nervous\nSystem Inflammation in a Mutant Mouse Model of GM1 Gangliosidosis"],"prefix":"10.2174","volume":"22","author":[{"given":"Xiaobing","family":"Wu","sequence":"first","affiliation":[{"name":"Beijing Ruicy Gene Therapy Institute For Rare Diseases,\nBeijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglan","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Guangzhou Newborn Screening Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou\nMedical University, Guangzhou Guangdong 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-9401","authenticated-orcid":true,"given":"Sichi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Guangzhou Newborn Screening Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou\nMedical University, Guangzhou Guangdong 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Ma","sequence":"additional","affiliation":[{"name":"Beijing Ruicy Gene Therapy Institute For Rare Diseases,\nBeijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyu","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Guangzhou Newborn Screening Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou\nMedical University, Guangzhou Guangdong 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Ruicy Gene Therapy Institute For Rare Diseases,\nBeijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefang","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Guangzhou Newborn Screening Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou\nMedical University, Guangzhou Guangdong 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Guangzhou Newborn Screening Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou\nMedical University, Guangzhou Guangdong 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Guangzhou Newborn Screening Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou\nMedical University, Guangzhou Guangdong 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","volume":"129","author":"Lang F.M.","year":"2020","unstructured":"Lang F.M.; Korner P.; Harnett M.; Karunakara A.; Tifft C.J.; The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis. Mol Genet Metab 2020,129(3),228-235","journal-title":"Mol Genet Metab"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11011-020-00650-y","volume":"36","author":"Priyanka K.","year":"2021","unstructured":"Priyanka K.; Madhana Priya N.; Magesh R.; A computational approach to analyse the amino acid variants of GLB1 protein causing GM1 Gangliosidosis. Metab Brain Dis 2021,36(3),499-508","journal-title":"Metab Brain Dis"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"100495","DOI":"10.1016\/j.ymgmr.2019.100495","volume":"20","author":"Ou L.","year":"2019","unstructured":"Ou L.; Kim S.; Whitley C.B.; Jarnes-Utz J.R.; Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling. Mol Genet Metab Rep 2019,20,100495","journal-title":"Mol Genet Metab Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1074\/jbc.RA119.009811","volume":"295","author":"Chen J.C.","year":"2020","unstructured":"Chen J.C.; Luu A.R.; Wise N.; Intracerebroventricular enzyme replacement therapy with \u03b2-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice. J Biol Chem 2020,295(39),13532-13555","journal-title":"J Biol Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.stemcr.2020.03.012","volume":"14","author":"Kajihara R.","year":"2020","unstructured":"Kajihara R.; Numakawa T.; Odaka H.; Novel drug candidates improve ganglioside accumulation and neural dysfunction in GM1 gangliosidosis models with autophagy activation. Stem Cell Reports 2020,14(5),909-923","journal-title":"Stem Cell Reports"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/187221412799015245","volume":"6","author":"Ortolano S.","year":"2012","unstructured":"Ortolano S.; Spuch C.; Navarro C.; Present and future of adeno associated virus based gene therapy approaches. Recent Pat Endocr Metab Immune Drug Discov 2012,6(1),47-66","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"E6881","DOI":"10.3390\/ijms21186881","volume":"21","author":"Ryckman A.E.","year":"2020","unstructured":"Ryckman A.E.; Brockhausen I.; Walia J.S.; Metabolism of glycosphingolipids and their role in the pathophysiology of lysosomal storage disorders. Int J Mol Sci 2020,21(18),E6881","journal-title":"Int J Mol Sci"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnmol.2020.00037","volume":"13","author":"Monaco A.","year":"2020","unstructured":"Monaco A.; Fraldi A.; Protein aggregation and dysfunction of autophagy- lysosomal pathway: A vicious cycle in lysosomal storage diseases. Front Mol Neurosci 2020,13,37","journal-title":"Front Mol Neurosci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.cell.2020.11.033","volume":"183","author":"Heckmann B.L.","year":"2020","unstructured":"Heckmann B.L.; Teubner B.J.W.; Tummers B.; LC3-associated endocytosis facilitates \u03b2-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s Disease. Cell 2020,183(6),1733-1734","journal-title":"Cell"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/glia.23663","volume":"67","author":"Karunakaran I.","year":"2019","unstructured":"Karunakaran I.; Alam S.; Jayagopi S.; Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation. Glia 2019,67(10),1859-1872","journal-title":"Glia"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-cellbio-100818-125242","volume":"35","author":"Stavoe A.K.H.","year":"2019","unstructured":"Stavoe A.K.H.; Holzbaur E.L.F.; Autophagy in neurons. Annu Rev Cell Dev Biol 2019,35,477-500","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2020.10.016","volume":"20","author":"Biferi M.G.","year":"2021","unstructured":"Biferi M.G.; Cohen-Tannoudji M.; Garcia-Silva A.; Systemic treatment of Fabry Disease using a novel aav9 vector expressing alpha-galactosidase A. Mol Ther Methods Clin Dev 2021,20,1-17","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/jnc.14672","volume":"148","author":"Kielian T.","year":"2019","unstructured":"Kielian T.; Lysosomal storage disorders: Pathology within the lysosome and beyond. J Neurochem 2019,148(5),568-572","journal-title":"J Neurochem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1002\/1873-3468.13980","volume":"594","author":"Vitner E.B.","year":"2020","unstructured":"Vitner E.B.; The role of brain innate immune response in lysosomal storage disorders: Fundamental process or evolutionary side effect? FEBS Lett 2020,594(22),3619-3631","journal-title":"FEBS Lett"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/brain\/awg089","volume":"126","author":"Jeyakumar M.","year":"2003","unstructured":"Jeyakumar M.; Thomas R.; Elliot-Smith E.; Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 2003,126(Pt 4),974-987","journal-title":"Brain"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1177\/1535370221993052","volume":"246","author":"Liu S.","year":"2021","unstructured":"Liu S.; Feng Y.; Huang Y.; A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy. Exp Biol Med (Maywood) 2021,246(11),1330-1341","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1159\/000509798","volume":"83","author":"Lin S.","year":"2020","unstructured":"Lin S.; Mei X.; Role of NLRP3 inflammasomes in neuroinflammation diseases. Eur Neurol 2020,83(6),576-580","journal-title":"Eur Neurol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12974-018-1137-1","volume":"15","author":"Wang Z.","year":"2018","unstructured":"Wang Z.; Meng S.; Cao L.; Chen Y.; Zuo Z.; Peng S.; Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment. J Neuroinflammation 2018,15(1),109","journal-title":"J Neuroinflammation"},{"key":"ref=19","first-page":"53569","volume":"117","author":"Feather-Schussler D.N.","year":"2016","unstructured":"Feather-Schussler D.N.; Ferguson T.S.;  A battery of motor tests in a neonatal mouse model of cerebral palsy. J Vis Exp 2016,117,53569","journal-title":"J Vis Exp"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","volume":"24","author":"Weismann C.M.","year":"2015","unstructured":"Weismann C.M.; Ferreira J.; Keeler A.M.; Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan. Hum Mol Genet 2015,24(15),4353-4364","journal-title":"Hum Mol Genet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"Schroder K.","year":"2010","unstructured":"Schroder K.; Tschopp J.; The inflammasomes. Cell 2010,140(6),821-832","journal-title":"Cell"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/hum.2018.206","volume":"31","author":"Hinderer C.","year":"2020","unstructured":"Hinderer C.; Nosratbakhsh B.; Katz N.; Wilson J.M.; A single injection of an optimized adeno-associated viral vector into cerebrospinal fluid corrects neurological disease in a murine model of GM1 gangliosidosis. Hum Gene Ther 2020,31(21-22),1169-1177","journal-title":"Hum Gene Ther"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2019.11.023","volume":"17","author":"Gray-Edwards H.L.","year":"2020","unstructured":"Gray-Edwards H.L.; Maguire A.S.; Salibi N.; 7T MRI predicts amelioration of neurodegeneration in the brain after AAV gene therapy. Mol Ther Methods Clin Dev 2020,17,258-270","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-981-15-4272-5_5","volume":"1207","author":"Ren H.","year":"2020","unstructured":"Ren H.; Wang G.; Autophagy and lysosome storage disorders. Adv Exp Med Biol 2020,1207,87-102","journal-title":"Adv Exp Med Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbrc.2007.12.187","volume":"367","author":"Takamura A.","year":"2008","unstructured":"Takamura A.; Higaki K.; Kajimaki K.; Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis. Biochem Biophys Res Commun 2008,367(3),616-622","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41420-020-00320-z","volume":"6","author":"Zheng T.","year":"2020","unstructured":"Zheng T.; Zhao C.; Zhao B.; Impairment of the autophagylysosomal pathway and activation of pyroptosis in macular corneal dystrophy. Cell Death Discov 2020,6,85","journal-title":"Cell Death Discov"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1016\/j.jmb.2020.02.012","volume":"432","author":"Zatyka M.","year":"2020","unstructured":"Zatyka M.; Sarkar S.; Barrett T.; Autophagy in rare (nonlysosomal) neurodegenerative diseases. J Mol Biol 2020,432(8),2735-2753","journal-title":"J Mol Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/acel.12409","volume":"15","author":"Aflaki E.","year":"2016","unstructured":"Aflaki E.; Moaven N.; Borger D.K.; Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages. Aging Cell 2016,15(1),77-88","journal-title":"Aging Cell"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566523222666220304092732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201682\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566523222666220304092732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T07:14:31Z","timestamp":1669792471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201682\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566523222666220304092732","relation":{},"ISSN":["1566-5232"],"issn-type":[{"type":"print","value":"1566-5232"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}